Stemedica Stock

stemedica.comHealthcare / BioTech & PharmaFounded: 2005Funding to Date: $82.12MM

Stemedica Cell Technologies is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions.

Register for Details

For more details on financing and valuation for Stemedica, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Stemedica.

Register Today

Team

Management Team

Craig Carlson
Chief Executive Officer
Roger Howe Ph.D
Chairman and Co-Founder
Maynard Howe Ph.D
Co-Founder, Vice Chairman & Chief Executive Officer
Nikolai Tankovich MD
President, Board Member and Chief Medical Officer
Alex Kharazi Ph.D
Chief Technology Officer
Lev Verkh Ph.D
Chief Regulatory and Clinical Development Officer

Board Members

Gary Petrucci
Maynard Howe Ph.D
Nikolai Tankovich MD
Sergey Leshkov
William Maloney MD
Byung-Geon Rhee Ph.D
Green Cross Holdings
Neal Matheson
Richard Mejia Jr.
Simon Guo
Anthony Marlon MD
Guochao Liu
Dirk O'Hara JD
Roger Howe Ph.D

Other companies like Stemedica in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.74B